Cue Biopharma CUE
NASDAQ CUE
$18.66 -0.10 (-0.53%)
At close: Nov 11, 2026 · 4:00 PM EST

Cue Biopharma (CUE) Gains from Investment Securities (2023 - 2025)

Updated

Analysis

Cue Biopharma (CUE) Gains from Investment Securities (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cue Biopharma 98.10 Mn 18.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1,000.00
Sep 30, 2023 5,000.00
Jun 30, 2023 34,000.00
Mar 31, 2023 57,000.00
API Access

Cue Biopharma Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=CUE&period=max&api_key=YOUR_API_KEY